3Chopt Investment Partners LLC Acquires New Holdings in HCA Healthcare, Inc. (NYSE:HCA)

3Chopt Investment Partners LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 955 shares of the company's stock, valued at approximately $330,000.

Other large investors have also recently added to or reduced their stakes in the company. Kessler Investment Group LLC acquired a new stake in HCA Healthcare during the first quarter valued at approximately $6,436,000. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of HCA Healthcare by 21.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,684 shares of the company's stock valued at $8,111,000 after acquiring an additional 4,236 shares in the last quarter. Achmea Investment Management B.V. grew its stake in HCA Healthcare by 31.4% in the 1st quarter. Achmea Investment Management B.V. now owns 56,819 shares of the company's stock valued at $19,634,000 after buying an additional 13,570 shares during the last quarter. Bartlett & CO. Wealth Management LLC increased its stake in shares of HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares during the period. Finally, Tranquility Partners LLC lifted its holdings in shares of HCA Healthcare by 1.2% during the first quarter. Tranquility Partners LLC now owns 16,645 shares of the company's stock worth $5,752,000 after buying an additional 195 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Stock Performance

NYSE:HCA traded down $1.53 during mid-day trading on Monday, hitting $377.78. The stock had a trading volume of 153,450 shares, compared to its average volume of 1,608,194. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The stock has a market cap of $90.88 billion, a price-to-earnings ratio of 16.80, a PEG ratio of 1.31 and a beta of 1.49. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company's 50 day simple moving average is $366.55 and its 200 day simple moving average is $337.09.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company posted $5.36 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's payout ratio is presently 12.81%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on HCA shares. Wall Street Zen lowered HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Friday. Guggenheim initiated coverage on HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating for the company. Robert W. Baird restated a "neutral" rating and issued a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Finally, Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Eight analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $395.71.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.